Hybrid Clustered Nanoparticles for Chemo-Antibacterial Combinatorial Cancer Therapy

Background: A great number of therapeutic limitations, such as chemoresistance, high dosage, and long treatments, are still present in cancer therapy, and are often followed by side effects such as infections, which represent the primary cause of death among patients. Methods: We report pH- and enzy...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortese, Barbara, D’Amone, Stefania, Testini, Mariangela, Ratano, Patrizia, Palamà, Ilaria Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769784/
https://www.ncbi.nlm.nih.gov/pubmed/31510037
http://dx.doi.org/10.3390/cancers11091338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769784/
https://www.ncbi.nlm.nih.gov/pubmed/31510037
http://dx.doi.org/10.3390/cancers11091338

Ejemplares similares